The Global Ulcerative Colitis Treatment market was valued at US$ 6.07 billion in 2025 and is expected to reach US$ 7.89 billion by 2034. The market is estimated to record a CAGR of 2.96% during 2026–2034. The increasing prevalence of inflammatory bowel diseases, rising awareness of gastrointestinal disorders, advancements in biologic therapies, and growing demand for targeted treatment...